Page 62 - Revista Argentina de Transfusión 1 - 2020
P. 62
22. Reikvam H, Marschner S, Apelseth TO, Goodrich R, Hervig T. 28. Corash L, Benjamin RJ. The role of hemovigilance and
The Mirasol® Pathogen Reduction Technology system and qual- postmarketing studies when introducing innovation into trans-
ity of platelets stored in platelet additive solution. Blood fusion medicine practice: the amotosalen-ultraviolet a patho-
Transfus. 2010;8(3):186–92. gen reduction treatment model. Transfusion. 2016;56(Supple-
23. Henschler R, Seifried E, Mufti N. Development of the S-303 ment 1):s29–38.
Pathogen Inactivation Technology for Red Blood Cell Concen- 29. Kleinman S. Pathogen inactivation: Emerging indications. Curr
trates. Transfus Med Hemotherapy. 2011;38(1):33–42. Opin Hematol. 2015;22(6):547–53.
24. Cognasse F, Osselaer J-C, Payrat JM, Chavarin P, Corash L, 30. Butler C, Doree C, Lj E, Trivella M, Hopewell S, Sj B, et al.
Garraud O. Release of immune modulation factors from plate- Pathogen-reduced platelets for the prevention of bleeding (
let concentrates during storage after photochemical pathogen Review ). 2013;(3).
inactivation treatment. Transfusion. 2008 May;48(5):809–13. 31. Estcourt LJ, Malouf R, Hopewell S, Trivella M, Doree C,
25. Inzunsa Cazares S, Jiménez Ramírez JV. The characteristics of Stanworth SJ, et al. Pathogen-reduced platelets for the preven-
college students’ statistical reasoning on hypothesis testing. tion of bleeding. Cochrane Database Syst Rev. 2017 Jul;(7):1–
Rev Latinoam Investig en Matemática Educ. 2013;16(2):179-211. 120.
26. Owusu-Ofori S, Kusi J, Owusu-Ofori A, Freimanis G, Olver C, 32. Seghatchian J, de Sousa G. Pathogen-reduction systems for
Martinez CR, et al. Treatment of whole blood with riboflavin blood components: The current position and future trends.
and uv light: Impact on malaria parasite viability and whole Transfus Apher Sci. 2006;35(3):189–96.
blood storage. Shock. 2015;44(5):33–8.
27. Allain JP, Owusu-Ofori A. Effect of plasmodium inactivation in
whole blood on the incidence of blood transfusio-transmitted
malaria in endemic regions: the African investigation of
Mirasol System (AIMS) randomised controlled trial. Lancet.
2016;(387):1753–61.
Pág. 56 AAHITC - Lavalleja 1214 (C1414DTZ) Vol. XLVI / N° 1 / 2020 Coordinadora: Dra. León de González, Graciela
Cdad. Aut. de Bs. As. - Argentina Págs. 49 / 56 Profesor invitado: Pérez Carrillo, José Arnulfo
Tel/Fax: (54-11)4771-2501 - L.Rot.
E-mail: aahitc@aahitc.org.ar
